C2 Pharma to exhibit at CPhI Worldwide 2017

C2 Pharma (formerly Centroflora CMS) is a Luxembourg-based pharmaceutical group established in 2014

C2 Pharma manufactures and distributes its active pharmaceutical ingredients and complex chemical compounds from phytochemical and chemical origins.

The current API product portfolio includes: atropine, digoxin, homatropine, pilocarpine, N-butylbromide scopolamine / hyoscine (SNBB) and reaches more than 100 pharmaceutical companies across the US, Western and Eastern Europe, South America, Asia, Africa and Australia.

Meet C2 Pharma at CPhI WW 2017; stand 11.0.B40

Companies